qlsyy.net (QLI) Company Total Sales Volume

Corporate emblem and logo of qlsyy.net (QLI)

The growth of Qilian International (QLI) is based on the demand for organic chemistry and traditional Chinese medicine. Monitoring of the company's sales confirms a long-term trend, where the 0.05 level serves as a critical mark. Stability is ensured by strict government licensing of the PRC pharmaceutical market. Meanwhile, financial results rely on the export of heparin and licorice, maintaining the operating margin within a safe range.

Qilian International Corp (QLI) Company Revenue: for the period 07/04/2022 - 08/17/2024

Comprehensive metric breakdowns and analytics for Qilian International Holding Group (QLI)

- share price and expert price forecast:
Comprehensive company analysis:Qilian International Holding QLI
Manufactured product of Qilian International Holding

To establish a fundamental baseline, investors must evaluate revenue dynamics, which reflect the actual sales volume of plant extracts within the production capacities of Qilian International (QLI). Analyzing the company's sales history confirms business scaling and its dependence on raw material market prices, allowing for an objective determination of the asset's resilience to operational risks.

Competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|SXTC (China SXT Pharmaceuticals, Inc.) - Company Total Sales|Company Revenue eupraxiapharma.com (EPRX)|Company Total Sales BHST|Company Revenue eXoZymes EXOZ|Company Sales Revenue ORMP|ENTX - Company Revenue|HYFT: Company Revenue|ABVC BioPharma, Inc (ABVC) - Company Revenue|Cumberland Pharma - Company Sales Revenue|QNTM (Quantum BioPharma Corp) - Revenue and Sales Volume|FibroGen, Inc. - Company Annual Revenue|Revenue and Sales Volume TELO|Company Gross Revenue Rani Therapeutics Holdings, Inc.|Company Revenue Synergy CHC Corp. SNYR|Revenue and Sales Volume rallybio.com RLYB|Lexaria Bioscience Corp. - Revenue and Sales Volume|PULM: Company Revenue|PTHL (ftzy.com.cn) - Company Sales|APM: Company Total Sales|LYRA (Lyra Therapeutics Inc) - Revenue and Sales Volume|Company Sales Volume IBO (Impact BioMedical)|Company Sales TNFA (TNF Pharmaceuticals)|Revenue and Sales Volume cbdMD Corp (YCBD)|Revenue and Sales Volume PRFX (PainReform)|Company Gross Revenue Auris Medical (CYTO)|LIPO - Company Revenue|Optinose (OPTN) - Company Sales|Pieris (PIRS) - Company Revenue|Company Annual Revenue PROC (Procaps Group S.A.)|Company Sales PTPI|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP